General Information on Voglibose
Generic Name : Voglibose
Latest prescription information about Voglibose. Learn its indications, dosage, how to take, when to take, when not to take, side effects, special precautions, warnings and its storage instructions . Also listed are the International and Indian trade name(s) of the drug and its price list.
ICD Code : Y42.3 |
Therapeutic Classification : Antidiabetics
Trade Names/Brand Names of Voglibose
India :
More... International :
Voglib, Volix
Why is Voglibose Prescribed? (Indications)
This medication is an alpha-glucosidase inhibitor, prescribed for diabetes mellitus.
When should Voglibose not be taken? (Contraindications)
Contraindicated in patients with inflammatory bowel disease, gastrointestinal obstruction, hernia, severe ketosis, diabetic hypersensitivity, pregnancy, lactation. Not to be used as single therapy in Insulin-dependent diabetes mellitus (IDDM).
What is the dosage of Voglibose?
PO- The recommended dose is 200-300 mcg 3 times/day.
How should Voglibose be taken?
It comes as a tablet to take by mouth, with food.
What are the warnings and precautions for Voglibose?
• Caution should be exercised in patients with history of abdominal laparotomy for gallstone ileus, Roemheld’s syndrome, stenosis, severe liver or kidney impairment, children, and elderly.
• Monitor liver function and sugar level regularly while taking this medication.
What are the side effects of Voglibose?
Flatulence, abdominal distension, diarrhea, pain, skin reactions, low blood sugar, increased LFT.
What are the other precautions for Voglibose?
Avoid excess dosage.
What are the storage conditions for Voglibose?
Oral: Store below 30°C.
This site complies with the HONcode standard for trustworthy health information: verify here.
Voglibose is an oral antidiabetic medication used to lower postprandial blood glucose levels [postprandial hyperglycemia] in people with diabetes mellitus. It is an alpha-glucosidase inhibitor that delays the digestion and absorption of sugar.